TITLE

FDA launches plan to prevent unnecessary harm from medication use

AUTHOR(S)
Traynor, Kate
PUB. DATE
January 2010
SOURCE
American Journal of Health-System Pharmacy;1/1/2010, Vol. 67 Issue 1, p7
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reports on the introduction of the U.S. Food and Drug Administration's (FDA's) Safe Use Initiative to prevent irrelevant harm from medication use. It notes that FDA is planning to work with the Centers for Disease Control and Prevention for the development of preventable medication harm based on population. It points out that FDA exceeds its mission of ensuring safe and effective medications. It also requires manufacturers to develop a risk evaluation and moderation strategy.
ACCESSION #
47426897

 

Related Articles

  • New Medication for Severe Malaria Available under an Investigational New Drug Protocol.  // Clinical Infectious Diseases;10/1/2007, Vol. 45 Issue 7, piii 

    The article reports that the U.S. Centers for Disease Control and Prevention's (CDC's) Investigational New Drug Application (IND) for intravenous artesunate went into effect on June 21, 2007. Under a protocol entitled "Intravenous Artesunate for Treatment of Severe Malaria in the United States,"...

  • Adverse Events Associated with Administration of Simulation Intravenous Fluids to Patients -- United States, 2014. Robyn, Misha P.; Hunter, Jennifer C.; Burns, Amy; Newman, Alexandra P.; White, Jennifer; Clement, Ernest J.; Lutterloh, Emily; Quinn, Monica; Edens, Chris; Epstein, Lauren; Seiber, Kathy; Duc Nguyen; Kallen, Alexander; Blog, Debra // MMWR: Morbidity & Mortality Weekly Report;3/6/2015, Vol. 64 Issue 8, p226 

    The article reports on adverse events associated with the administration of simulation intravenous fluids to U.S. patients in 2014. Topics discussed include an investigation by the New York State Department of Health (NYSDOH) and the U.S. Centers for Disease Control and Prevention (CDC) into the...

  • Manufacturers argue against mandatory training for opioid prescribers. Traynor, Kate // American Journal of Health-System Pharmacy;1/15/2010, Vol. 67 Issue 2, p96 

    The article reports that manufacturers of opioid medications have requested U.S. Food and Drug Administration (FDA) to adopt a careful method for changing prescription practices as the agency develops a risk evaluation and mitigation strategy (REMS) for some of these medications. According to...

  • Cessation shelf is smokin'.  // Drug Store News;1/10/2011, Vol. 33 Issue 1, p46 

    The article reports on the programs initiated by the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration.

  • Handwashing Versus Alcohol-Based Gels---FDA Information.  // Journal of Environmental Health;Sep2003, Vol. 66 Issue 2, p40 

    The U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) are working together to control the transmission of pathogens that can result in foodborne illnesses. Transmission of pathogenic bacteria, viruses, and parasites from raw food or from ill workers...

  • FDA, CDC award jobs worth up to $540m. Dickson, Virgil // PRWeek (U.S. Edition);Nov2012, Vol. 15 Issue 11, p7 

    The article discusses the Food and Drug Administration of the U.S. and the U.S. Centers for Disease Control and Prevention that has received 540 million dollars as a multi-year anti-smoking marketing contract.

  • Pfizer promotes Zithromax for childhood ear infections, flouting CDC guidelines.  // Medical Marketing & Media;Nov99, Vol. 34 Issue 11, p27 

    Reports on the efforts of Pfizer Inc. to promote Zithromax to patients and physicians in the United States. Recommendation of the antibiotic by the Centers for Disease Control and Prevention; Zithromax's Food and Drug Administration-approved indication for pediatric acute otitis media; Emphasis...

  • Ticked Off! Chang, Maria L. // Science World;05/10/99, Vol. 55 Issue 14, p7 

    Offers information on the spread of Lyme disease in some areas in the United States (US), according to the US Centers for Disease Control and Prevention. Information on the bacteria that causes the disease; Information on the vaccine that would prevent Lyme disease, approved by the US Food and...

  • Update: MERS-CoV Continues to Strike. Deresinski, Stan // Infectious Disease Alert;Jul2013, Vol. 32 Issue 10, p115 

    The article offers update on the new coronavirus officially called MERS-CoV or Middle East respiratory syndrome coronavirus that has caused new, often fatal infections with 55 laboratory-confirmed cases of infection worldwide as of June 7, 2013. Saudi Arabia has the most cases with 40 confirmed...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics